News and Trends 1 Feb 2022
Ribbon Biolabs Pushes DNA Synthesis Length Limits with €18M Series A
The Viennese biotech startup Ribbon Biolabs has raised an €18M Series A round to reduce the costs of synthesizing long DNA molecules, which could accelerate research into synthetic biology and…